Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in

Donn Spight1, Bruce Trapnell, Bin Zhao

  • 1Department of Surgery, University of Cincinnati, Division of Pulmonary Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio, USA.

Shock (Augusta, Ga.)
|February 19, 2008
PubMed

Insights

Granulocyte-macrophage-colony-stimulating factor (GM-CSF) deficiency surprisingly improved survival in a sepsis model, linked to lower inflammatory cytokine responses from peritoneal macrophages. This highlights a novel role for GM-CSF in sepsis pathogenesis.

Area of Science:

  • Immunology
  • Infectious Disease
  • Cell Biology

Background:

  • Granulocyte-macrophage-colony-stimulating factor (GM-CSF) is crucial for innate immunity and macrophage differentiation via PU.1.
  • GM-CSF-deficient mice previously showed impaired bacterial clearance and susceptibility to infection.
  • The role of GM-CSF in peritonitis and sepsis, particularly concerning peritoneal macrophages, was investigated.

Purpose of the Study:

  • To investigate the role of GM-CSF and peritoneal macrophages in survival during experimentally induced peritonitis/sepsis.
  • To examine the impact of GM-CSF deficiency on pathogen clearance, cytokine responses, and survival in a murine cecal ligation and puncture (CLP) model.
  • To elucidate the mechanisms underlying altered survival in GM-CSF-deficient mice during sepsis.

Main Methods:

  • Murine cecal ligation and puncture (CLP) model to induce peritonitis/sepsis.
  • Analysis of survival rates, bacterial peritonitis, and microbial flora composition.
  • Measurement of peritoneal and serum cytokine levels (TNF-alpha, IL-6).
  • Peritoneal lipopolysaccharide (LPS) instillation studies.
  • In vitro studies using peritoneal macrophages from GM-CSF-deficient and wild-type mice.
  • Bone marrow chimera studies involving GM-CSF-deficient/PU.1+ and GM-CSF-deficient/PU.1- macrophages.

Main Results:

  • Surprisingly, GM-CSF-deficient mice exhibited significantly improved survival after CLP compared to wild-type mice.
  • Survival in GM-CSF-deficient mice correlated with lower peritoneal and serum levels of TNF-alpha and IL-6.
  • GM-CSF-deficient mice showed improved survival and reduced inflammatory responses after LPS instillation.
  • Peritoneal macrophages from GM-CSF-deficient mice secreted lower levels of TNF-alpha and IL-6 in vitro.
  • Restoration of GM-CSF-dependent PU.1+ peritoneal macrophages into GM-CSF-deficient mice conferred susceptibility to death.

Conclusions:

  • GM-CSF and its downstream transcription factor PU.1-dependent peritoneal macrophage responses are critical determinants of survival in experimental peritonitis/sepsis.
  • Dysfunctional GM-CSF/PU.1-mediated macrophage responses, characterized by reduced pro-inflammatory cytokine production, confer resistance to sepsis in mice.
  • These findings have significant implications for developing novel therapeutic strategies for sepsis and related inflammatory conditions.